BB-10901

{
  "id": "MLC-T-ONC-000938",
  "term": "BB-10901",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of some types of cancer, including Wilms tumor, neuroblastoma, rhabdomyosarcoma, and other types of soft tissue sarcoma. BB-10901 contains a monoclonal antibody that binds to a protein called CD56 on some types of cancer cells. It also contains an anticancer drug called DM1, which may help kill cancer cells after BB-10901 binds to them. BB-10901 is a type of antibody-drug conjugate. Also called lorvotuzumab mertansine.",
  "expansions": [
    "lorvotuzumab mertansine"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/bb-10901/"
}